Literature DB >> 6209862

Pain--mechanics and management.

H L Fields, J D Levine.   

Abstract

In the past two decades there has been remarkable progress in understanding the neural mechanisms of pain. However, chronic pain is poorly understood and, by definition, poorly managed. In addition to hyperactivity of the sympathetic nervous system and damage to normal inhibitory mechanisms, social and psychological factors play a major role in producing the disability of chronic pain. New approaches to manage chronic pain include nonopiate drugs, transcutaneous electral nerve stimulation and psychological and behavioral methods. A nervous system network has recently been described that suppresses pain. This analgesic action is mediated by endogenous opioid peptides (endorphins) and by biogenic amines. The analgesia network can be activated either by electral stimulation or by opiates such as morphine or methadone.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209862      PMCID: PMC1021824     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  52 in total

1.  Pain and illness behaviour: a comparative study.

Authors:  I Pilowsky; N D Spence
Journal:  J Psychosom Res       Date:  1976       Impact factor: 3.006

2.  Amitriptyline in the prophylaxis of migraine. Effectiveness and relationship of antimigraine and antidepressant effects.

Authors:  J R Couch; D K Ziegler; R Hassanein
Journal:  Neurology       Date:  1976-02       Impact factor: 9.910

3.  Properties of afferent nerve impulses originating from a neuroma.

Authors:  P D Wall; M Gutnick
Journal:  Nature       Date:  1974-04-26       Impact factor: 49.962

4.  Reflex activity in postganglionic fibres within skin and muscle nerves elicited by somatic stimuli in chronic spinal cats.

Authors:  G Horeyseck; W Jänig
Journal:  Exp Brain Res       Date:  1974       Impact factor: 1.972

5.  Intravenous regional sympathetic block with guanethidine.

Authors:  J G Hannington-Kiff
Journal:  Lancet       Date:  1974-05-25       Impact factor: 79.321

6.  Inhibitory and excitatory factors influencing the receptive fields of lamina 5 spinal cord cells.

Authors:  P Hillman; P D Wall
Journal:  Exp Brain Res       Date:  1969       Impact factor: 1.972

7.  Somatovisceral pathway: rapidly conducting fibers in the spinal cord.

Authors:  H L Fields; D L Winter
Journal:  Science       Date:  1970-03-27       Impact factor: 47.728

Review 8.  Pain mechanisms: a new theory.

Authors:  R Melzack; P D Wall
Journal:  Science       Date:  1965-11-19       Impact factor: 47.728

9.  Chronic tension headache--treated with amitriptyline--a double-blind study.

Authors:  S Diamond; B J Baltes
Journal:  Headache       Date:  1971-10       Impact factor: 5.887

10.  Identification of two related pentapeptides from the brain with potent opiate agonist activity.

Authors:  J Hughes; T W Smith; H W Kosterlitz; L A Fothergill; B A Morgan; H R Morris
Journal:  Nature       Date:  1975-12-18       Impact factor: 49.962

View more
  5 in total

1.  [Chronic pain in general practice : Results from pain specialists].

Authors:  A Heymanns; H Rudolf; H Schneider-Nutz; K Salem; K Strick; M Zenz
Journal:  Schmerz       Date:  2017-08       Impact factor: 1.107

Review 2.  Modern techniques of pain management.

Authors:  S L Perlman
Journal:  West J Med       Date:  1988-01

3.  A practical approach to improving pain control in cancer patients.

Authors:  M L Brigden; J B Barnett
Journal:  West J Med       Date:  1987-05

4.  Evaluation of serum level of substance P and tissue distribution of NK-1 receptor in endometrial cancer.

Authors:  Naghmeh Gharaee; Leila Pourali; Amir Hossein Jafarian; Seyed Isaac Hashemy
Journal:  Mol Biol Rep       Date:  2018-09-17       Impact factor: 2.316

5.  Pain Education During the Coronavirus Pandemic: The Introduction of Pain Medicine During the Pre-Clinical Years.

Authors:  Benjamin Mirman; Taif J Mukhdomi; Praveen Rajaguru; Ira Whitten; Keith Fragoza; Afreen Siddiqui; Alexios Carayannopoulos; Mark C Kendall
Journal:  Pain Med       Date:  2022-04-08       Impact factor: 3.637

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.